C57BL/6NCya-Mbd2em1flox/Cya
Common Name:
Mbd2-flox
Product ID:
S-CKO-03665
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mbd2-flox
Strain ID
CKOCMP-17191-Mbd2-B6N-VA
Gene Name
Product ID
S-CKO-03665
Gene Alias
MBD2a
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
18
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Mbd2em1flox/Cya mice (Catalog S-CKO-03665) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000074058
NCBI RefSeq
NM_010773
Target Region
Exon 2
Size of Effective Region
~0.7 kb
Detailed Document
Overview of Gene Research
Mbd2, or methyl-CpG-binding domain 2, is a “reader” protein that interprets DNA methylome-encoded information. It is associated with transcriptional regulation, chromatin structure modulation, and is involved in multiple biological processes such as cell differentiation, development, and disease [4]. It can bind to methylated CpG DNA, which is crucial for its functions in various pathways.
In mice, depletion of Mbd2 in macrophages protected against bleomycin-induced pulmonary fibrosis. Mbd2 deficiency attenuated TGF-β1 production and reduced M2 macrophage accumulation in the lung. Mechanistically, Mbd2 bound to the Ship promoter, repressed Ship expression, and enhanced PI3K/Akt signaling to promote the macrophage M2 program [1].
In tumor-related studies, knockdown of MBD2 in LUAD cells (A549 and H1975 cell lines) and B16F10 cells significantly attenuated cell migration, invasion, and epithelial-mesenchymal transition (EMT). MBD2 bound to the methylated CpG DNA within the DDB2 promoter, repressing DDB2 expression to promote tumor metastasis [2].
In cholangiocarcinoma (CCA), MBD2 was upregulated, promoting cell proliferation, migration, and chemoresistance. It interacted with WDR5, bound to the promoter of ABCB1, promoted H3K4 trimethylation through KMT2A, and activated ABCB1 expression [3].
In Th17-dominant asthma, MBD2 expression was increased, and it regulated Th17 cell differentiation by negatively regulating MINK1 [5].
In breast cancer, genetic knockout of Mbd2 in MMTV-PyMT transgenic mice impeded primary tumor growth and lung metastasis, and abrogated the expression of key determinants in epithelial-to-mesenchymal transition and impaired the activation of the PI3K/AKT pathway [6].
In septic acute kidney injury (AKI), inhibition of MBD2 by siRNA or knockout improved the survival rate, attenuated AKI, renal cell apoptosis, and inflammatory factor production. MBD2 directly bound to the promoter region CpG islands of PKCη, and activated PKCη/p38MAPK and the ERK1/2 axis [7].
In conclusion, Mbd2 plays diverse and significant roles in multiple biological processes and disease conditions. Through gene knockout studies in mouse models, its functions in pulmonary fibrosis, tumor metastasis, cholangiocarcinoma progression, Th17-dominant asthma, breast cancer, and septic AKI have been revealed. These findings provide potential therapeutic targets for these diseases by targeting Mbd2 [1,2,3,5,6,7].
References:
1. Wang, Yi, Zhang, Lei, Wu, Guo-Rao, Xiong, Weining, Wang, Cong-Yi. 2021. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. In Science advances, 7, . doi:10.1126/sciadv.abb6075. https://pubmed.ncbi.nlm.nih.gov/33277324/
2. Zhang, Lei, Wang, Siyuan, Wu, Guo-Rao, Yong, Tuying, Wang, Cong-Yi. 2023. MBD2 facilitates tumor metastasis by mitigating DDB2 expression. In Cell death & disease, 14, 303. doi:10.1038/s41419-023-05804-1. https://pubmed.ncbi.nlm.nih.gov/37142578/
3. Wang, Da, Chen, Junsheng, Wu, Guanhua, He, Ruizhi, Chen, Yongjun. 2024. MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5. In Journal of experimental & clinical cancer research : CR, 43, 272. doi:10.1186/s13046-024-03188-4. https://pubmed.ncbi.nlm.nih.gov/39350229/
4. Menafra, Roberta, Stunnenberg, Hendrik G. 2014. MBD2 and MBD3: elusive functions and mechanisms. In Frontiers in genetics, 5, 428. doi:10.3389/fgene.2014.00428. https://pubmed.ncbi.nlm.nih.gov/25538734/
5. Chen, Zhifeng, Shang, Yulin, Yuan, Yu, Liu, Shaokun, Xiang, Xudong. 2022. MBD2 mediates Th17 cell differentiation by regulating MINK1 in Th17-dominant asthma. In Frontiers in genetics, 13, 959059. doi:10.3389/fgene.2022.959059. https://pubmed.ncbi.nlm.nih.gov/36303542/
6. Mahmood, Niaz, Arakelian, Ani, Szyf, Moshe, Rabbani, Shafaat A. 2024. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition. In Experimental & molecular medicine, 56, 959-974. doi:10.1038/s12276-024-01205-2. https://pubmed.ncbi.nlm.nih.gov/38556549/
7. Xie, Yuxin, Liu, Bohao, Pan, Jian, Dong, Zheng, Zhang, Dongshan. 2020. MBD2 Mediates Septic AKI through Activation of PKCη/p38MAPK and the ERK1/2 Axis. In Molecular therapy. Nucleic acids, 23, 76-88. doi:10.1016/j.omtn.2020.09.028. https://pubmed.ncbi.nlm.nih.gov/33335794/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen